NCT06018441View on ClinicalTrials.gov

A Study to Evaluate the Quality of Life in Male and Female Adult Participants With Severe Asthma Treated With Dupilumab in a Real-world Setting

Active, not recruitingOBSERVATIONAL
Enrollment

112

Participants

Timeline

Start Date

October 3, 2023

Primary Completion Date

October 3, 2025

Study Completion Date

October 3, 2025

Conditions
Asthma
Trial Locations (1)

Unknown

Investigational Site, France

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT06018441 - A Study to Evaluate the Quality of Life in Male and Female Adult Participants With Severe Asthma Treated With Dupilumab in a Real-world Setting | Biotech Hunter | Biotech Hunter